ABCL vs BLNK · rev $12.4M vs rev $42.5M
Abcellera Biologics Inc (ABCL) versus Blink Charging Co (BLNK) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Blink Charging Co (BLNK) is a engineering & construction company listed on NASDAQ.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Latest reported BLNK revenue for 2026-06-30 was $42.5M. Net income was -$17.6M. BLNK currently screens at market cap $94.0M.
ABCL currently screens at market cap $1.12B. BLNK currently screens at market cap $94.0M.
Not investment advice. Open the ABCL and BLNK stock pages for the full models.
Not investment advice.